连续流左心室辅助装置支持患者基于血压的结局:INTERMACS分析
基于INTERMACS注册数据,分析16,155例连续流LVAD术后存活患者的血压与不良事件关联。血压与生存呈双峰风险关联,低血压(MAP≤75 mmHg)死亡风险最高,调整风险增加35%-42%;高血压(MAP>100 mmHg)风险亦增加17%-20%。结论支持MAP目标>75 mmHg且<90 mmHg,应避免过度降压。
要点
- LVAD支持患者MAP中位数84 mmHg,Doppler中位数85 mmHg,SBP中位数99 mmHg。
- MAP≤75 mmHg者3年生存58%±1.8%,低于正常、高、极高MAP组的70%±0.9%、71%±1.5%、63%±3.0%。
- 轴流LVAD中,SBP每升高10 mmHg与卒中风险增加相关(HR 1.08,95%CI 1.04-1.13),MAP无此关联。
核心结论
- LVAD支持期间血压极端值增加不良事件风险,支持MAP目标>75 mmHg且<90 mmHg。
- 低血压(MAP≤75 mmHg)带来的死亡风险最高,应避免过度血压控制。
研究设计与样本
- 基于INTERMACS注册的回顾性队列分析,纳入连续流LVAD术后存活患者n=16,155。
- 按血压百分位分组:低(<25th)、正常(25-75th)、高(75th-95th)、极高(>95th),用Cox回归评估血压与不良事件关联。
主要发现
- 3年生存率:低MAP(≤75 mmHg)组58%±1.8%,正常、高、极高MAP组分别为70%±0.9%、71%±1.5%、63%±3.0%。
- 慢性低MAP(≤75 mmHg)、Doppler(≤80 mmHg)、SBP(<90 mmHg)者调整死亡风险比正常或高BP者高35%-42%(p≤0.0001)。
- MAP>100 mmHg、Doppler≥105 mmHg、SBP≥120 mmHg者调整死亡风险比正常血压者高17%-20%(p<0.05)。
- 轴流LVAD患者中,SBP每升高10 mmHg与卒中发生率增加相关(HR 1.08,95%CI 1.04-1.13),MAP无此关联。
关键数值与推荐
- 建议MAP目标>75 mmHg且<90 mmHg。
- 避免过度血压控制,Doppler开放压不应假定代表MAP。
临床怎么用
- LVAD患者血压管理应维持MAP在75-90 mmHg之间,避免低于75 mmHg或高于100 mmHg。
- 轴流LVAD患者需关注SBP升高与卒中风险,SBP≥120 mmHg时调整死亡风险增加。
- Doppler开放压不能直接等同于MAP,临床应结合多种血压测量方式评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An optimal blood pressure (BP) range to mitigate morbidity and mortality on left ventricular assist device (LVAD) support has not been clearly defined. METHODS: Average Doppler opening pressure, mean arterial pressure (MAP), and/or systolic blood pressure (SBP) were calculated in operative survivors (n = 16,155) of LVAD support in the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). BP distributions were used to group patients into low (BP <25th percentile), normal (25-75th percentile), high (75th-95th percentile), and very high (>95th percentile). Associations between BP and adverse events were evaluated using Cox regression (hazard ratio[HR], 95% confidence interval). RESULTS: The median (25th, 75th) MAP, Doppler, and SBP (mm Hg) during continuous flow LVAD support were 84 (77, 90), 85 (80, 92), and 99 (90, 107) mm Hg, respectively. BP had a bimodal risk association with survival. At 3 years, survival was 58% ± 1.8% in those with low MAP (≤75 mm Hg) vs 70% ± 0.9%, 71% ± 1.5%, and 63% ± 3.0% in the those with normal, high, or very high average MAP, respectively. Patients with chronically low MAP (≤75 mm Hg), Doppler (≤80 mm Hg), and SBP (<90 mm Hg) had 35%-42% higher adjusted hazards of death than patients with normal or high BP (p ≤ 0.0001). Patients with MAP >100 mm Hg, Doppler ≥105 mm Hg, and SBP ≥120 mm Hg had 17%-20% higher adjusted hazards of death than those with normal pressures (p < 0.05). In patients on axial flow LVADs, elevated SBP (HR 1.08 [95% confidence interval, 1.04-1.13] per 10 mm Hg increase) but not MAP correlated with increased incident of stroke. CONCLUSIONS: In INTERMACS, BP extremes during LVAD support increase the risk for adverse events, supporting a MAP goal >75 mm Hg and <90 mm Hg. Hypotension conferred the highest risk for mortality. Excessive BP control should be avoided, and Doppler opening pressure should not be assumed to represent MAP in all patients.
引用
- Cowger JA, Shah P, Pagani FD, et al. Outcomes based on blood pressure in patients on continuous flow left ventricular assist device support: An Interagency Registry for Mechanically Assisted Circulatory Support analysis. J Heart Lung Transplant. 2019. PMID: 31831209. doi:10.1016/j.healun.2019.11.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。